Atlas FDA

LJB

11 FDA 510(k) clearances · Product code

112 daysmedian time to decision
152 days90th percentile
11clearances measured

FDA profile

Official device name
Enzyme Linked Immunoabsorbent Assay, Rubeola Igg
Device class
Class I (low risk)
Regulation
21 CFR 866.3520
Medical specialty
Microbiology
FDA definition
The qualitative detection of measles specific IgG antibodies in serum or plasma.
Adverse events (MAUDE)
2020: 11
Reports received by FDA, not confirmed device causation - volume tracks device popularity as much as risk.
Sort:Newest firstOldest first

Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free

RecordFirmDate
DIAMEDIX IS-MEASLES IGG TEST SYSTEM (K974552)Diamedix Corp.1998-01-28
QUANTA LITE RUBEOLA (MEASLES) IGG (K971620)Inova Diagnostics, Inc.1997-07-22
BARTELS RUBEOLA IGM EIA (K922335)Baxter Diagnostics, Inc.1992-09-02
BARTELS RUBEOLA IGG EIA (K922330)Baxter Diagnostics, Inc.1992-09-02
VIRATEST-DIA(TM) MEASLES (RUBEOLA) (K910290)Virus Reference Laboratory, Inc.1992-03-18
RUBEOLA IGM ELISA TEST (K904083)Gull Laboratories, Inc.1991-01-03
MEASLES IGG MICROASSAY (K903961)Diamedix Corp.1990-12-28
RUBEOLA IGG ELISA TEST (K904854)Gull Laboratories, Inc.1990-12-04
RUBEOLA IGG CLIN-ELISA TEST SYSTEM, CAT. #4600 (K891990)Clinical Sciences, Inc.1989-06-15
VIRGO(TM) MEASLES IGG ELISA (K873925)Electro-Nucleonics Laboratories, Inc.1988-02-24
MEASELISA TEST KIT (K821762)M.A. Bioproducts1982-07-30

Track LJB automatically

Every clearance here is in the API, with alerts when new ones post.